Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK.Issue Date
2020
Metadata
Show full item recordCitation
Lim KHJ, Gomes F. ESMO20 YO for YO: highlights on oncogene-addicted NSCLC. ESMO Open. 2020;6(1):100026.Journal
ESMO OpenDOI
10.1016/j.esmoop.2020.100026PubMed ID
33399088Additional Links
https://dx.doi.org/10.1016/j.esmoop.2020.100026Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.esmoop.2020.100026
Scopus Count
Collections
Related articles
- ESMO20 YO for YO: highlights on metastatic NSCLC-Keynote 024 update.
- Authors: Mariamidze E, Mezquita L
- Issue date: 2021 Feb
- ESMO20 YO for YO: highlights on upper GI tumours.
- Authors: Cardone C, Pihlak R, Smyth E
- Issue date: 2021 Feb
- ESMO20 YO for YO: highlights on metastatic renal cell carcinoma-the CheckMate-9ER trial.
- Authors: Kfoury M, Oing C
- Issue date: 2021 Feb
- ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer.
- Authors: Punie K, Matikas A
- Issue date: 2021 Feb
- ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib.
- Authors: Lambertini M, Punie K
- Issue date: 2021 Feb